Timing of onset of contraceptive effectiveness in depo-provera users. II. Effects on ovarian function

Fertility and Sterility

Volumn 70, Issue 5, 1998, Pages 817-820

  Petta, Carlos A ^a   Faúndes, Anibal ^a   Dunson, Thomas R ^a   Ramos, Marcia ^a   DeLucio, Mara ^a   Faúndes, Daniel ^a   Bahamondes, Luis ^a  

^a NONE

Author keywords

Back up contraception; Contraception; Depo Provera; Estradiol; Ovulation; Progesterone

Indexed keywords

ESTRADIOL; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; PROGESTERONE;

ADULT; ARTICLE; CELL VIABILITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HORMONE DETERMINATION; HUMAN; HUMAN EXPERIMENT; MENSTRUAL CYCLE; NORMAL HUMAN; OVARY FUNCTION; OVULATION INHIBITION; PREDICTION; PRIORITY JOURNAL; SEXUAL BEHAVIOR; TRANSVAGINAL ECHOGRAPHY; UTERINE CERVIX MUCUS;

AMERICAS; BIOLOGY; BRAZIL; CLINICAL RESEARCH; CONTRACEPTION; CONTRACEPTIVE AGENTS; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE AGENTS, PROGESTIN; CONTRACEPTIVE EFFECTIVENESS; CONTRACEPTIVE METHODS; DEMOGRAPHIC FACTORS; DEPO-PROVERA; DEVELOPING COUNTRIES; FAMILY PLANNING; GENITALIA; GENITALIA, FEMALE; INJECTABLES; LATIN AMERICA; MEDROXYPROGESTERONE ACETATE; MENSTRUAL CYCLE; MENSTRUATION; OVARIAN EFFECTS; OVARY; OVULATION; PHYSIOLOGY; POPULATION; POPULATION DYNAMICS; REPRODUCTION; RESEARCH METHODOLOGY; RESEARCH REPORT; SOUTH AMERICA; TIME FACTORS; UROGENITAL SYSTEM;

ADOLESCENT; ADULT; CONTRACEPTIVE AGENTS, FEMALE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MENSTRUAL CYCLE; OVARY; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0032213811     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00309-4     Document Type: Article

References (15)

1. Fraser I.S., Weisberg E. A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate. Med J Aust. 1:(1 Suppl):1981;3-19.
2. Siriwongse T., Snidvonga W., Tantayaporn P., Leepipalboon S. Effect of depot-medroxyprogesterone acetate on serum progesterone levels, when administered on various cycle days. Contraception. 26:1982;487-493.
3. Shelton J.D., Angle M.A., Jacobstein R.A. Medical barriers to access to family planning. Lancet. 340:1993;1334-1335.
4. Petta C., Faúndes A., Dunson T.R., Ramos M., DeLucio M., Faúndes D., et al. Timing of onset of contraceptive effectiveness in Depo-Provera users. I. Changes in cervical mucus. Fertil Steril. 69:1998;252-257.
5. Ritchie W.G.M. Ultrasound in the evaluation of normal and induced ovulation. Fertil Steril. 43:1985;167-181.
6. Bahamondes L., Faúndes D., Marchi N., Ramos M., Perrotti M., Cristofoletti M.L. The influence of human chorionic gonadotrophin administration upon the next ovarian cycle. Hum Reprod. 10:1995;533-535.
7. Brache V., Alvarez F., Faúndes A., Cochon L., Thevenin F. Effect of pre-ovulatory insertion of Norplant implants over luteinizing hormone secretion and follicular development. Fertil Steril. 65:1996;110-114.
8. March C.M., Goebelsmann U., Nakamura R.M., Mishel D.R. Jr. Roles of estradiol and progesterone in eliciting the midcycle luteinizing hormone and follicle-stimulating hormone surges. J Clin Endocrinol Metab. 49:1979;507-511.
9. Hoff J.D., Quigley M.E., Yen S.S. Hormonal dynamics at midcycle a re-evaluation . J Clin Endocrinol Metab. 57:1983;792-796.
10. Liu J.H., Yen S.S. Induction of midcycle gonadotropin surge by ovarian steroids in women a critical evaluation . J Clin Endocrinol Metab. 57:1983;797-802.
11. Shoupe D., Mishel D.R. Jr, Page M.A., Madkour H., Spitz I.M., Lobo R.A. Effects of antiprogesterone RU486 in normal women. II. Administration in late follicular phase. Am J Obstet Gynecol. 157:1987;1421-1426.
12. Permezel J.M., Lenon E.A., Roberts I., Cooke I.D. Acute effects of progesterone and the antiprogestin RU486 on gonadotropin secretion in the follicular phase of a menstrual cycle. J Clin Endocrinol Metab. 68:1989;960-965.
13. Batista M.C., Cartledge T.P., Zellmer A.W., Nieman L.K., Merrian G.R., Loriaux D.L. Evidence for a critical role of progesterone in the regulation of midcycle gonadotropin surge and ovulation. J Clin Endocrinol Metab. 74:1992;565-570.
14. Batista M.C., Cartledge T.P., Zellmer A.W., Nieman L.K., Loriaux D.L., Merrian G.R. The antiprogestin RU486 delays the midcycle gonadotropin surge and ovulation in gonadotropin-releasing hormone-induced cycles. Fertil Steril. 62:1994;28-34.
15. Wilcox A.J., Weinberg C.R., Baird D.D. Timing of sexual intercourse in relation to ovulation effects on the probability of conception, survival of the pregnancy, and sex of the baby . N Engl J Med. 333:1995;1517-1521.